Human genetic studies of PD patient cohorts have previously suggested that common variants at LRRK2 function coordinately with variants at a second PD risk-associated locus, PARK16, to increase PD risk, as human genetic variants at these 2 loci impact PD risk non-additively10, 11. The gene discussed is LRRK2; the disease is Parkinson disease.